TABLE 2.

Unadjusted Analysis Results for PMN and TAT by Clinic

	Overall			Multiple sclerosis			Oncology			Inflammatory
	HSSP	Non-HSSP	P value	HSSP	Non-HSSP	P value	HSSP	Non-HSSP	P value	HSSP	Non-HSSP	P value
PMN (n = 1,396)	n = 971	n = 425		n = 58	n = 39		n = 609	n = 153		n = 304	n = 233
n (%)	63 (6.5)	42 (9.9)	0.027	2 (3.5)	8 (20.5)	0.013	42 (6.9)	9 (5.9)	0.654	19 (6.3)	25 (10.7)	0.061
TAT (n = 1,188)	n = 779	n = 409		n = 56	n = 31		n = 503	n = 208		n = 220	n = 170
Days, median (IQR)	3 (1-6)	4 (1-10)	<0.001	2 (1-5)	3 (1-10)	0.103	3 (1-6)	3 (1-7)	0.620	2 (1-5)	6 (1-18)	<0.001

HSSP = health system specialty pharmacy; IQR = interquartile range; PMN = primary medication nonadherence; TAT = turnaround time.